|
CKD Bio Corp - Company Profile Snapshot
| Company Profile: |
CKD Bio Corp |
| Ticker: |
063160 |
| Exchanges: |
SEO |
| 2008 Sales: |
83,393,000,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
KOREA (SOUTH) |
| Employees: |
259 |
Business Description
CKD Bio Corp. The Company's principal activity is the providing of pharmaceutical products. The Company mainly provides antibiotic ingredients, consisting of potassium clavulanates, demethylchlortetracyclines (DMCTs) and rifampicins. It also develops immunosuppressive agents including cyclosporin and tacrolimus, and remedies for diabetes such as acarbose. The Company exports its products to China, the United States, Europe, Southeast Asia, Africa, South America and the Middle East. The Company operates a research laboratory concentrated on the production of therapeutic pharmaceuticals.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
